Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
Condition(s):Guillain-Barre SyndromeLast Updated:November 15, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Guillain-Barre SyndromeLast Updated:November 15, 2023Not yet recruiting
Condition(s):Sickle Cell Disease; PainLast Updated:October 3, 2023Recruiting
Condition(s):Rabies; Rabies Human; Rabies Virus Infection; PediatricsLast Updated:August 21, 2023Recruiting
Condition(s):HFRS (Hemorrhagic Fever With Renal Syndrome)Last Updated:August 24, 2023Recruiting
Condition(s):Sensory Neuropathy; Small Fiber NeuropathyLast Updated:December 27, 2023Not yet recruiting
Condition(s):CIDP; Immunoglobulin Deficiency; Chronic Inflammatory Demyelinating PolyneuropathyLast Updated:August 14, 2023Recruiting
Condition(s):Primary Immune DeficiencyLast Updated:May 17, 2023Recruiting
Condition(s):Newly Diagnosed Immune Thrombocytopenia in Children, First Line TreatmentLast Updated:March 1, 2023Recruiting
Condition(s):Kawasaki DiseaseLast Updated:February 28, 2024Recruiting
Condition(s):Habitual Abortion; Recurrent Pregnancy Loss; Fertility Disorders; MiscarriageLast Updated:September 10, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.